Treatment of status epilepticus

Neurologic Clinics

Volumn 19, Issue 2, 2001, Pages 347-369

  Smith, Brien J ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CLOBAZAM; CLONAZEPAM; CLORAZEPATE; DIAZEPAM; FOSPHENYTOIN SODIUM; LORAZEPAM; MIDAZOLAM; NITRAZEPAM; OXAZEPAM; PHENYTOIN; PROPOFOL; VALPROIC ACID;

ADULT; ALGORITHM; CHILD; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE COURSE; ELECTROENCEPHALOGRAM; EMERGENCY MEDICINE; EPILEPTIC STATE; FIRST AID; HEART DISEASE; HUMAN; HYPOXIA; INTENSIVE CARE; METABOLIC ACIDOSIS; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; UNITED STATES;

EID: 0034995026     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70022-0     Document Type: Article

References (126)

1. Plasma levels of diazepam after parenteral and rectal administration in children
2. Effect of prehospital treatment on the outcome of status epilepticus in children
3. Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus
4. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy
5. Complex febrile seizures
6. Convulsive disorders: Status epilepticus
7. Advances in the management of refractory status epilepticus
8. Management approaches to prolonged seizures and status epilepticus
9. Reversal of sedation by prolonged infusion of flumazenil (Anexate, Ro 15-1788)
10. Propofol and epilepsy: Time to clarify
11. Role of propofol in refractory status epilepticus
12. Propofol: An update of its use in anaesthesia and conscious sedation
13. Modern concepts of status epilepticus
14. A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children
15. The influence of diazepam or lorazepam on the frequency of endotracheal intubation in childhood status epilepticus
16. A proposed international classification of epileptic seizures
17. Proposal for revised clinical and electroencephalographic classification of epileptic seizures
18. Nasal versus oral midazolam for sedation of anxious children undergoing laceration repair
19. Chronic epileptogenic cellular alterations in the limbic system after status epilepticus
20. Residual electrographic status epilepticus after control of overt clinical seizures
21. Very-high-dose phenobarbital for refractory status epilepticus in children
22. Seizures and opisthotonos after propofol anesthesia
23. Status epilepticus in children, adults, and the elderly
24. Epidemiology of status epilepticus
25. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus
26. Safety of intravenous valproate
27. Rectal diazepam for prehospital pediatric status epilepticus
28. Rectal use of benzodiazepines
29. Midazolam treatment of acute and refractory status epilepticus
30. Status epilepticus: Risk factors and complications
31. The treatment of status epilepticus by electrostimulation of deep brain structures
32. Treatment of status epilepticus with diazepam (Valium)
33. Classification of status epilepticus
34. Use of injectable valproic acid in status epilepticus: A pilot study
35. Electroconvulsive therapy for status epilepticus
36. Neurosurgical treatment of refractory status epilepticus
37. Rectal administration of antiepileptic drugs in children
38. Pharmacoeconomic considerations in treatment options for acute seizures
39. Convulsive status epilepticus in children
40. Status epilepticus: Current concepts
41. Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus
42. Rhabdomyolysis and hypoxia' associated with prolonged propofol infusion in children
43. Status epilepticus: Epidemiologic considerations
44. An overview of benzodiazepines in seizure management
45. Buccal route for benzodiazepines in treatment of seizures?
46. Refractory status epilepticus in adults
47. Treatment of status epilepticus with acupuncture
48. Status epilepticus: A perspective from the neuroscience intensive care unit
49. Assessing the outcomes in patients with nonconvulsive status epilepticus: Nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity
50. Intranasal midazolam in patients with status epilepticus
51. Rectal administration of diazepam in solution in the acute treatment of convulsions in infants and children
52. Attainment of therapeutic phenytoin concentrations following administration of loading doses of fosphenytoin: A metaanalysis
53. Propofol in prehospital treatment of convulsive status epilepticus
54. Intranasal midazolam for childhood seizures
55. Out-of-hospital midazolam for status epilepticus
56. Double-blind study of lorazepam and diazepam in status epilepticus
57. Status Epilepticus
58. Treatment of status epilepticus with lorazepam
59. The biochemical basis and pathophysiology of status epilepticus
60. Status epilepticus
61. Status epilepticus
62. Status epilepticus: An overview of the clinical problem
63. It's time to revise the definition of status epilepticus
64. Results of a controlled trial of benzodiazepines for the treatment of status epilepticus in the prehospital setting
65. Seizures associated with propofol anesthesia
66. Low morbidity and mortality of status epilepticus in children
67. Anticonvulsant drugs: Mechanisms of action
68. Acute cellular alterations in the hippocampus after status epilepticus
69. Propofol for treating status epilepticus
70. Metabolic factors during prolonged seizures and their relation to nerve cell death
71. Successful treatment of intractable epilepsia partialis continua with multiple subpial transections
72. First attempt at treatment of experimental status epilepticus in animals and spontaneous status epilepticus in man with diazepam (Valium)
73. Status epilepticus in well-oxygenated rats causes neuronal necrosis
74. Topiramate reduces neuronal injury after experimental status epilepticus
75. Myoclonic status epilepticus
76. Nasal rather than rectal benzodiazepines in the management of acute childhood seizures
77. Treatment of refractory generalized tonic-clonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin
78. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: Five case reports
79. Management of acute seizure episodes
80. Intravenous diazepam administration by paramedics in the acute treatment of status epilepticus in children
81. Intravenous valproate: Experience in neurosurgery. Fourth Int Symp Sodium Valproate and Epilepsy
82. The tolerability and safety of valproate sodium injection given as an intravenous infusion
83. Safety of high-dose rapid infusion of intravenous valproic acid
84. Pharmacokinetic optimisation of benzodiazepine therapy for acute seizures: Focus on delivery routes
85. Emergency treatment of status epilepticus
86. Generalized tonic-clonic status epilepticus: Causes, treatment, complications, and predictors of case fatality
87. Generalized convulsive status epilepticus: Pathophysiology and treatment
88. Lorazepam Intensol for the management of hospitalized pediatric patients with epilepsy
89. Buccal absorption of midazolam: Pharmacokinetics and EEG pharmacodynamics
90. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: A randomised trial
91. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens
92. Refractory status epilepticus: Response to ketamine
93. Tohic-clonic status epilepticus
94. The use of clobazam, midazolam, and nitrazepam in epilepsy
95. Epileptic brain damage. Pathophysiology and neurochemical pathology
96. Prolongation of midazolam half-life following sustained infusion for status epilepticus
97. Treatment of status epilepticus in children with rectal sodium valproate
98. Treatment of refractory status epilepticus with propofol: Clinical and pharmacokinetic findings
99. Emergency treatment of acute seizures and status epilepticus
100. The secondarily generalized tonic-clonic seizure: A videotape analysis
101. Letters
102. Determinants of mortality in status epilepticus
103. Use of intramuscular midazolam for status epilepticus
104. Status epilepticus
105. Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus
106. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus
107. The role of benzodiazepines in the management of status epilepticus
108. Utility of the EEG pattern as a predictor of success in the treatment of generalized convulsive status epilepticus
109. Generalized convulsive status epilepticus in the adult
110. Status epilepticus
111. A comparison of four treatments for generalized convulsive status epilepticus
112. Generalized convulsive status epilepticus
113. VA Status Epilepticus Cooperative Study Group: Treatment of status epilepticus if first drug fails
114. Rectal administration of sodium valproate in status epilepticus
115. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients
116. Lorazepam in status epilepticus
117. Diagnosis and treatment of status epilepticus on a neurological intensive care unit
118. Nasal benzodiazepines for management of acute childhood seizures?
119. Status epilepticus
120. Use of parenteral antiepileptic drugs and the role of fosphenytoin
121. Preanesthetic sedation of preschool children using intranasal midazolam
122. Propofol infusion for the treatment of status epilepticus
123. Treatment of convulsive status epilepticus: Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus
124. Prognostic factors for pentobarbital therapy for refractory generalized status epilepticus
125. Sublingual lorazepam in childhood serial seizures